Enclomiphene Monotherapy — TRT Alternative
Enclomiphene citrate 12.5–25mg/day as standalone TRT alternative for men with secondary hypogonadism who want to raise testosterone while preserving fertility and testicular function. Blocks estrogen receptors in the hypothalamus, increasing endogenous LH/FSH. Does not suppress natural production — fundamentally different from exogenous testosterone.
Duration
—
Steps
1
Total Weeks
—
Route
Oral
Protocols
1
Source
community practice
Protocol Timeline
| Step | Weeks | Dose | Compound | Note |
|---|---|---|---|---|
| 1 | 0 | 25 mg | Enclomiphene | 25mg/day ongoing. Monitor testosterone response at 4-6 weeks. |
Rationale
NOT FDA-approved (as of 2026). Available via compounding pharmacies. Best candidates: men under 40 with secondary hypogonadism who want to preserve fertility. Monitor T, LH, FSH, E2, semen analysis. BSSM 2025 position statement supports enclomiphene for male hypogonadism.
Compounds Used
Related Tools
Track this regimen in Doseline
Adopt Enclomiphene Monotherapy — TRT Alternative as a template, set reminders for every step, and log doses as you go. All free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.